Antibiotice S.A. is a prominent Romanian pharmaceutical company with a rich tradition in drug manufacturing, established in 1955. Headquartered in Iași, Romania, the company is a national leader in producing anti-infective medications and a significant player in the generic drugs market. Antibiotice S.A. is committed to research and development, manufacturing a diverse portfolio that includes sterile injectable powders, capsules, tablets, topical preparations, and Active Pharmaceutical Ingredients (APIs). Notably, it is a world-leading producer of Nystatin. With exports to over 70 countries, Antibiotice S.A. upholds rigorous quality standards (EU-GMP certified) and focuses on providing accessible, high-quality healthcare solutions globally.
The Iași headquarters serves as the nerve center for all corporate activities, including strategic management, research and development, extensive manufacturing operations for diverse pharmaceutical forms, stringent quality assurance, and coordination of domestic and international sales and marketing.
The campus boasts modern, EU-GMP compliant manufacturing facilities, advanced R&D laboratories, and dedicated production lines for a wide array of pharmaceutical products. It is one of the largest and most important pharmaceutical industrial platforms in Romania and Southeastern Europe.
The work environment at Antibiotice S.A. is characterized by a strong emphasis on scientific excellence, uncompromising quality, continuous innovation, and teamwork. It fosters professional growth and a commitment to public health, building on its legacy as a key employer in the region.
The Iași headquarters is pivotal to Antibiotice S.A.'s operations and identity. It's not only the historical birthplace of the company but also a vital contributor to Romania's pharmaceutical self-sufficiency, public health, and the regional economy, particularly through its production of essential medicines.
Antibiotice S.A. maintains a significant global footprint, exporting its pharmaceutical products to over 70 countries worldwide, spanning Europe, North America, Asia (including key markets in Southeast Asia and CIS countries), and Africa. Its global operations encompass international sales and marketing, navigating complex regulatory landscapes for product registration in diverse markets, managing a global supply chain, and pursuing strategic business development opportunities. The company is globally recognized as a leading manufacturer of Nystatin API, supplying this critical active ingredient to major pharmaceutical companies internationally.
Strada Valea Lupului nr. 1
Iași
Județul Iași
Romania
Address: MD-2060, bd. Dacia 15/1, of.1, Chișinău, Republica Moldova
To enhance the availability and accessibility of Antibiotice's pharmaceutical products to patients and healthcare professionals in Moldova, strengthening its market position in the country.
Address: R.804, 8th floor, TD Business Center, No. 20 Lot, Lê Hồng Phong St, Ngô Quyền District, Hải Phòng City, Vietnam
To establish a strong foothold in the rapidly growing Southeast Asian pharmaceutical market, ensuring direct access and supply of Antibiotice's diverse product portfolio to meet regional healthcare needs.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Antibiotice' leadership includes:
Antibiotice has been backed by several prominent investors over the years, including:
Based on publicly available information and news analysis for Antibiotice S.A. covering the last 12 months (mid-2023 to mid-2024), there have been no widely reported major C-suite executive hires or departures. The core operational executive management team appears stable. Changes at the Board of Directors level may occur as per regulatory filings but typically do not represent C-suite operational turnovers.
Discover the tools Antibiotice uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Antibiotice S.A. typically uses a standard corporate email format. Based on common practices in Romanian companies and the pharmaceutical industry, the most probable email structure combines the employee's first and last names with the company domain.
[first].[last]@antibiotice.ro
Format
ioan.nani@antibiotice.ro
Example
85%
Success rate
Ziarul Financiar (zf.ro) • March 26, 2024
Antibiotice Iași announced it has signed a credit agreement worth 100 million RON with CEC Bank. These funds are designated for financing the company's investment projects and bolstering its working capital, supporting its ongoing development and operational needs....more
Profit.ro / Bucharest Stock Exchange (BVB) • February 29, 2024
According to its preliminary financial results for 2023, Antibiotice Iași recorded a substantial 75% increase in net profit, reaching over 63 million RON. The company's turnover also grew by 13%, amounting to nearly 560 million RON, indicating a strong financial performance and market expansion....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Antibiotice, are just a search away.